Sign in
4

Changes in Ownership

NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-20-026302

Chief Financial Officer sold 1,741 shares at $102.49 ($178,435)

From the SEC's structured data for this filing

Trades in this filing

ABERNETHY MATT · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-04-28 Sale : show line 1 in the form −1,741 $102.49 $178,435 5,953 D
Open-market sales · 1,741 sh · avg $102.49 · $178,435
Loading xslF345X03/doc4.xml…